Reply
The National Union of Healthcare Workers announced Wednesday a 96% vote in favor of a five-day strike to potentially take place next month at Keck Hospital of USC, USC Norris Comprehensive Cancer Center and several university clinics and call centers. (Shutterstock / TonelsonProductions)
LOS ANGELES, CA Negotiations are scheduled to resume Thursday between the union representing more than 1,500 health care workers at USC- affiliated health care facilities and call centers and the university, one day after the announcement of the authorization of a five-day strike next month.
The National Union of Healthcare Workers announced Wednesday a 96% vote in favor of a five-day strike to potentially take place next month at Keck Hospital of USC, USC Norris Comprehensive Cancer Center and several university clinics and call centers.
USC Norris Comprehensive Cancer Center forms Wellness HUBs with Lazarex Cancer Foundation eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: HPV infection causes cells to undergo changes. If not treated these cells can, over time, become cancer cells. view more
Credit: National Cancer Institute
Today, doctors and scientists across America at National Cancer Institute (NCI)-designated cancer centers and other organizations issued a joint statement urging the nation s health care systems, physicians, parents and children, and young adults to get the human papillomavirus (HPV) vaccination back on track.
Dramatic drops in annual well visits and immunizations during the COVID-19 pandemic have caused a significant vaccination gap and lag in vital preventive services among U.S. children and adolescents especially for the HPV vaccine. The pandemic also has exacerbated health disparities, leaving Black, Indigenous and other people of color; rural; and sexual minority adolescents at even greater risk for missed doses of this cancer prevention vaccine.
E-Mail
Scientists at VCU Massey Cancer Center have identified a protein that operates in tandem with a specific genetic mutation to spur lung cancer growth and could serve as a therapeutic target to treat the disease.
Mutations in the p53 gene are found in more than half of all cancers, but it remains difficult to effectively target the gene with drugs even decades after its discovery. Though previous research has shown that p53 acts as a tumor suppressor and initiates cancer cell death in its natural state, a new study led by Sumitra Deb, Ph.D., suggests that gain-of-function (GOF) mutations a type of mutation where the changed gene has an added function turn p53 into an oncogene, causing cells to replicate uncontrollably and contribute to cancer development.
/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical.